Effects of nebivolol in obese African Americans with hypertension (NOAAH): markers of inflammation and obesity in response to exercise-induced stress

We sought to determine whether the antihypertensive drug nebivolol has beneficial effects on vascular markers of inflammation and oxidation in obese African-American patients with hypertension when exposed to exercise-induced stress. Forty-three obese, African-American subjects with hypertension wer...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of human hypertension 2011-03, Vol.25 (3), p.196-202
Hauptverfasser:	Merchant, N, Rahman, S T, Ferdinand, K C, Haque, T, Umpierrez, G E, Khan, B V
Format:	Artikel
Sprache:	eng
Schlagworte:	631/250/256/2516 631/92/436/108 692/699/2743/393 692/699/75/243 Adiponectin Adiponectin - blood African Americans Antihypertensive Agents - therapeutic use Antihypertensives Arterial hypertension. Arterial hypotension Benzopyrans - therapeutic use Biological and medical sciences Biological markers Biomarkers - blood Blood and lymphatic vessels Blood Glucose - drug effects Cardiology. Vascular system Cell adhesion molecules Cholesterol, HDL - blood Cholesterol, LDL - blood Clinical manifestations. Epidemiology. Investigative techniques. Etiology Dosage and administration Drug therapy Epidemiology Ethanolamines - therapeutic use Exercise Female Fitness equipment Health Administration Health aspects Humans Hypertension Hypertension - complications Hypertension - drug therapy Identification and classification Inflammation Inflammation - blood Interleukin 6 Interleukin-6 - blood Leptin Leptin - blood Lipids - blood Male Medical sciences Medicine Medicine & Public Health Middle Aged Nebivolol Obesity Obesity - complications original-article Oxidation Patients Physiological aspects Public Health Stress (Physiology) Stress, Physiological - drug effects Treatment Outcome Vascular cell adhesion molecule 1 Vascular Cell Adhesion Molecule-1 - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!